Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer - Join Clinical Trial NCTNCT05744687
How to Join This Clinical Trial - NCTNCT05744687
Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Locally Advanced or Metastatic Breast Cancer. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Locally Advanced or Metastatic Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Locally Advanced or Metastatic Breast Cancer
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2, PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05744687 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 9 locations. Find a study site near you:
Clinical Research Site
Fuzhou, Fujian 350014 - China
Status: RECRUITING
Clinical Research Site
Guangzhou, Guangdong 510060 - China
Status: RECRUITING
Clinical Research Site
Guiyang, Guizhou 550000 - China
Status: RECRUITING
Clinical Research Site
Anyang, Henan 455001 - China
Status: RECRUITING
Clinical Research Site
Luoyang, Henan 450052 - China
Status: RECRUITING
Clinical Research Site
Pingxiang, Jiangxi 337099 - China
Status: RECRUITING
Clinical Research Site
Chang chun, Jilin 130022 - China
Status: RECRUITING
Clinical Research Site
Yinchuan, Ningxia 750003 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100142 - China
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE2, PHASE3 clinical trial for Locally Advanced or Metastatic Breast Cancer:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships